RANDOMISED CONTROLLED TRIAL OF DRUG LEVEL VERSUS CLINICALLY BASED DOSING OF INFLIXIMAB MAINTENANCE THERAPY IN IBD: FINAL RESULTS OF THE TAXIT STUDY

(1) KU Leuven Laboratory for Therapeutic and Diagnostic Antibodies

(2) UZ Leuven Department of Gastroenterology

(3) University of Liège Systems and Modeling Unit

(4) KU Leuven Research Centre for Pharmaceutical Care & Pharmaco-economics



This item was part of the Opening Plenary Session session at UEG Week 2013

This item can be cited as: United European Gastroenterology Journal; 2013: 1 (Supplement 1) A1

You may be interested in:

Neostrategies in integrating omics data in pancreatic cancer
English, Presentation, European Pancreatic Club (EPC), European Federation International Society for Digestive Surgery (EFISDS), 2015

Categorisation:

  • Clinical Specialty
    • 'IBD-ology'
  • Diagnosis and Management
    • Medical management
  • Disease
    • Inflammatory bowel disease
  • Format
    • Abstract
  • Language
    • English
  • Year
    • 2013